MedComm is a peer‐reviewed, online OA journal that publishes the pioneer works of medicine on the basis of novelty, timeliness and significance on human health.

Joined August 2020
🎉Congratulations! In the recently released JCR Impact Factor 2025, MedComm-Oncology maintained an IF of 8.5, placing it in the Q1 category for Oncology, ranking 40/333. Welcome to submit your next manuscripts to MedComm-Oncology! #JCR2026 #TrustedJournals #ImpactFactor
91
🧬 #OriginalArticle in #MedComm_Future_Medicine 🔬 GABAergic TH2 Amacrine Cells Participate in Spontaneous Wave Activity in the Developing Retina 🔗 doi.org/10.1002/mef2.70075 #Retina #AmacrineCells #GABAergic #RetinalDevelopment #Neuroscience @EyeResearchers @oaklandu
16
🧬 #Review in #MedComm 🔬 Mitochondria as the Hub of Apoptosis: A Comprehensive Insight From Mitochondria to Interactions With Other Organelles 🔗 doi.org/10.1002/mco2.70911 #Mitochondria #Apoptosis #CellDeath #CancerTherapy #OrganelleInteraction #PrecisionMedicine
97
🧬 #Review in #MedComm 🧠 Cell Death in Neurodegenerative Diseases: Molecular Mechanisms and Therapeutic Targets 🔗 doi.org/10.1002/mco2.70915 #NeurodegenerativeDiseases #CellDeath #Neuroscience #TherapeuticTargets
1
65
The 13th West China International Forum for Emergency Medicine (#WCIFEM2026) concluded in Chengdu, China, focusing on value-based emergency care and the smart transformation of emergency medicine. Read more👇#EmergencyMedicine #CriticalCare #ValueBasedCare #WestChinaHospital
1
53
🧬 #Review in #MedComm-Future Medicine 🔬 Advances in Research on the Anti-Tuberculosis Effects of Active Components in Chinese Herbal Medicine 🔗 doi.org/10.1002/mef2.70061 #Tuberculosis #ChineseHerbalMedicine #DrugResistance #GuangdongMedicalUniversity
53
🧬 #Review in #MedComm-Biomaterials and Applications 🔬 Dual-Drug-Loaded Liposomes: Design Strategies, Mechanistic Insights, and Therapeutic Applications in Cancer 🔗 doi.org/10.1002/mba2.70060 @bhupro #Liposomes #DrugDelivery #Nanomedicine #CancerTherapy
45
🧬 #Review in #MedComm 🔬 Pathways of Protein Secretion in Prokaryotes and Eukaryotes: Molecular Mechanisms, Biological Functions, and Therapeutic Opportunities 🔗 doi.org/10.1002/mco2.70798 #ProteinSecretion #CellBiology #OpenAccess
43
#Review in #MedComm #Nonclassical #MHC1 Molecules: Emerging Therapeutic Targets in Next-Generation #Immunotherapy doi.org/10.1002/mco2.70742 Nonclassical MHC-I molecules (HLA-E, HLA-F, HLA-G, CD1, MR1) offer next-generation targets for immunotherapy. #HLA #AntigenPresentation
43
🎉Congratulations! In the recently released JCR Impact Factor 2025, MedComm maintained an IF of 14.1, placing it in the Q1 category for Medicine, Research & Experimental, ranking 11/191. Welcome to submit your next manuscripts to MedComm!#JCR2026 #TrustedJournals #ImpactFactor
1
6
313
#Letter in #MedComm_Oncology A #Retrospective #Cohort Study: Association of Helicobacter Pylori With #Radiotherapy Efficacy in Metastatic Colorectal Cancer and #Recurrence Risk Following Preoperative Therapy doi.org/10.1002/mog2.70074 #HelicobacterPylori #Hp #ColorectalCancer
81
#Article in #MedComm_Biomaterials_and_Applications The Use of #FN-Silk Networks as Extracellular Matrix-Mimicking Support for 3D In Vitro Breast Cancer Models Improved the Model's Reproducibility in Drug Sensitivity doi.org/10.1002/mba2.70052 @KTHuniversity #3Dmodel #BreastCancer
47
#Review in #MedComm_Oncology The Dual Role of #Autophagy in #Cancer: Mechanisms and Therapeutic Strategies doi.org/10.1002/mog2.70064 It expands the functional scope of autophagy, and provides a solid foundation for preventive and #therapeutic strategies against cancer. @UM_1981
1
45